Ryan S. Youland - Concepedia

Author

Ryan S. Youland

Mayo Clinic ORCID

Also Known As

R. S. Youland, R. Youland, R.S. Youland, Ryan S Youland, Ryan S. Youland, Ryan Youland, T Kazda

Publications

738

Citations

H-Index

Concepts

All Affiliations

Mayo Clinic Mayo Clinic in Arizona Saint Luke's Hospital WinnMed The University of Texas MD Anderson Cancer Center

About

Ryan S. Youland is an author at Mayo Clinic specializing in medicine, high-grade gliomas, and glioma.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	268
2	Health Sciences	2	2	31
3	Engineering	1	1	38
4	Cell Biology	1	1	142
5	Geriatrics	1	1	17

Ryan S. Youland

Publications

723

Citations

H-Index

Page 1

	Year	Citations
Biopsy validation of 18F-DOPA PET and biodistribution in gliomas for neurosurgical planning and radiotherapy target delineation: results of a prospective pilot study D.H. Pafundi, Nadia N. Laack, Ryan S. Youland, Neuro-Oncology	2013	212
The role of LAT1 in 18F-DOPA uptake in malignant gliomas Ryan S. Youland, Gaspar J. Kitange, Timothy E. Peterson, Journal of Neuro-Oncology Neuro-oncologyOncogenic AgentMedicinePathologyCancer Biology	2012	142
Molecular profiling of long-term IDH-wildtype glioblastoma survivors Danielle M. Burgenske, Jie Yang, Paul A. Decker, Neuro-Oncology	2019	80
Changes in presentation, treatment, and outcomes of adult low-grade gliomas over the past fifty years Ryan S. Youland, David A. Schomas, Paul D. Brown, Neuro-Oncology	2013	56
Adult Low-grade Glioma Ryan S. Youland, Paul D. Brown, Caterina Giannini, American Journal of Clinical Oncology	2012	47
Prognostic Factors and Survival Patterns in Pediatric Low-grade Gliomas Over 4 Decades Ryan S. Youland, Shariq S. Khwaja, David A. Schomas, Journal of Pediatric Hematology/Oncology	2013	39
Prospective trial evaluating the sensitivity and specificity of 3,4-dihydroxy-6-[18F]-fluoro-l-phenylalanine (18F-DOPA) PET and MRI in patients with recurrent gliomas Ryan S. Youland, Deanna Pafundi, Debra H. Brinkmann, Journal of Neuro-Oncology Positron Emission TomographyNeuro-oncologyEngineeringGliomaMedicine	2018	38
Health related quality of life (HRQOL) in long-term survivors of pediatric low grade gliomas (LGGs) Chika Nwachukwu, Ryan S. Youland, Catherine Chioreso, Journal of Neuro-Oncology Health Related QualityQuality Of LifeNeuro-oncologyLife AssessmentPediatrics	2014	21
The impact of adjuvant therapy for patients with high-risk diffuse WHO grade II glioma Ryan S. Youland, C.R. Kreofsky, David A. Schomas, Journal of Neuro-Oncology High-risk Diffuse WhoMedicineCancer ManagementIi GliomaNeurology	2017	19
Initial results of a phase II trial of 18F-DOPA PET-guided re-irradiation for recurrent high-grade glioma William G. Breen, Ryan S. Youland, Sharmila Giri, Journal of Neuro-Oncology Initial ResultsGliomaRadiation TherapyMedical ImagingMedicine	2022	19

Page 1